Abstract

Several step‐based daily targets have been widely circulated, but there is a lack of empirical population‐based evidence to support such guidance. We examined dose‐response associations between step count and classical CVD risk markers (glycated hemoglobin, high density lipoprotein cholesterol, triglycerides, and C‐reactive protein) in 4665 adults (aged 46 years; 51.4% female) in a cross‐sectional study. Step counts were measured from a thigh mounted accelerometer (activPAL) worn over 7 days. The shape of the dose‐response curve for most risk markers was “L‐shaped,” with linear risk reduction up to around 10 000 steps a day. Controlling for stepping intensity did not materially alter our results.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.